LETICIA CORTES: Open Payments
NPI 1124639000 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 86 payments from 24 companies in 2025. Trend: 2023 $23 · 2024 $1,176 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $615 |
| Biogen, Inc. | 7 | $176 |
| PFIZER INC. | 9 | $168 |
| Eisai Inc. | 6 | $145 |
| Teva Pharmaceuticals USA, Inc. | 5 | $134 |
| ARGENX US, INC. | 3 | $75 |
| Genentech USA, Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| TG Therapeutics, Inc. | 2 | $49 |
| Lundbeck LLC | 3 | $49 |
Products named: QULIPTA, UBRELVY, Leqembi, BOTOX, NURTEC ODT, VUMERITY, AUSTEDO XR, Ocrevus Zunovo.
Industry payments across TX — which companies pay providers there.
